Comparison of placebo and bromocriptine in the treatment of patients with normoprolactinaemic amenorrhoea

Fourteen women with normoprolactinaemic amenorrhoea were treated with bromocriptine (2.5 mg twice daily) for a period ranging from 4 to 17 weeks, while a matched group fo 19 amenorrhoeic women were treated with a placebo (one tablet twice daily) for 4 to 12 weeks. About half of the patients in both...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of obstetrics and gynaecology Vol. 85; no. 10; p. 773
Main Authors Crosignani, P G, Reschini, E, Lombroso, G C, Arosio, M, Peracchi, M
Format Journal Article
LanguageEnglish
Published England 01.10.1978
Subjects
Amenorrhea - drug therapy
Bromocriptine - therapeutic use
Clinical Trials as Topic
Female
Humans
Placebos
Progesterone - blood
Prolactin - blood
Online AccessGet more information

Cover

More Information
Summary:Fourteen women with normoprolactinaemic amenorrhoea were treated with bromocriptine (2.5 mg twice daily) for a period ranging from 4 to 17 weeks, while a matched group fo 19 amenorrhoeic women were treated with a placebo (one tablet twice daily) for 4 to 12 weeks. About half of the patients in both groups had at least one episode of vaginal bleeding during treatment. There was no clear difference in the menstrual and ovulatory pattern between placebo and bromocriptine groups.
ISSN:0306-5456